1
|
Adams JW, Duprey M, Khan S, Cance J, Rice DP, Bobashev G. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study. Harm Reduct J 2023; 20:150. [PMID: 37848945 PMCID: PMC10580611 DOI: 10.1186/s12954-023-00888-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Accepted: 10/09/2023] [Indexed: 10/19/2023] Open
Abstract
BACKGROUND Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD). The primary concern expressed by critics of these policies is the potential for buprenorphine diversion. However, the population-level effects of increased buprenorphine diversion are unclear. If replacing the use of heroin or fentanyl, use of diverted buprenorphine could be protective. METHODS Our study aim was to estimate the impact of buprenorphine diversion on opioid overdose using an agent-based model calibrated to North Carolina. We simulated the progression of opioid misuse and opioid-related outcomes over a 5-year period. Our status quo scenario assumed that 50% of those prescribed buprenorphine diverted at least one dose per week to other individuals with OUD and 10% of individuals with OUD used diverted buprenorphine at least once per week. A controlled prescription only scenario assumed that no buprenorphine would be diverted, while an increased diversion scenario assumed that 95% of those prescribed buprenorphine diverted and 50% of individuals with OUD used diverted buprenorphine. We assumed that use of diverted buprenorphine replaced the use of other opioids for that day. Sensitivity analyses increased the risk of overdose when using diverted buprenorphine, increased the frequency of diverted buprenorphine use, and simulated use of diverted buprenorphine by opioid-naïve individuals. Scenarios were compared on opioid overdose-related outcomes over the 5-year period. RESULTS Our status quo scenario predicted 10,658 (credible interval [CI]: 9699-11,679) fatal opioid overdoses. A scenario simulating controlled prescription only of buprenorphine (i.e., no diversion) resulted in 10,741 (9895-11,650) fatal opioid overdoses versus 10,301 (9439-11,244) within a scenario simulating increased diversion. Compared to the status quo, the controlled prescription only scenario resulted in a similar number of fatal overdoses, while the scenario with increased diversion of buprenorphine resulted in 357 (3.35%) fewer fatal overdoses. Even when increasing overdose risk while using diverted buprenorphine and incorporating use by opioid naïve individuals, increased diversion did not increase overdoses compared to a scenario with no buprenorphine diversion. CONCLUSIONS A similar number of opioid overdoses occurred under modeling conditions with increased rates of buprenorphine diversion among persons with OUD, with non-statistical trends toward lower opioid overdoses. These results support existing calls for low- to no-barrier access to buprenorphine for persons with OUD.
Collapse
Affiliation(s)
| | | | - Sazid Khan
- RTI International, Research Triangle, NC, USA
| | | | - Donald P Rice
- Division of Infectious Disease, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
| | | |
Collapse
|
2
|
Adams JW, Jones K, Preiss S, Hadley E, Segelman M. Evaluating Policies to Decrease the Risk of Introducing SARS-CoV-2 Infections to Nursing Home Facilities. J Appl Gerontol 2023:7334648231155873. [PMID: 36749786 PMCID: PMC10360919 DOI: 10.1177/07334648231155873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
We used an individual-based microsimulation model of North Carolina to determine what facility-level policies would result in the greatest reduction in the number of individuals with SARS-CoV-2 entering the nursing home environment from 12/15/2021 to 1/3/2022 (e.g., Omicron variant surge). On average, there were 14,287 (Credible Interval [CI]: 13,477-15,147) daily visitors and 17,168 (CI: 16,571-17,768) HCW coming from the community into 426 nursing home facilities. Policies requiring a negative rapid test or vaccinated status for visitors resulted in the greatest reduction in the number of individuals with SARS-CoV-2 infection entering the nursing home environment with a 29.6% (26.9%-32.0%) and 24.0% (CI: 22.2%-25.5%) reduction, respectively. Policies halving visits (21.2% [20.0%-28.2%]), requiring all vaccinated HCW to receive a booster (7.8% [CI: 7.4%-8.7%]), and limiting visitation to a primary visitor (6.5% [CI: 3.5%-9.7%]) reduced infectious contacts to a lesser degree.
Collapse
Affiliation(s)
| | - Kasey Jones
- 6856RTI International, Research Triangle, NC, USA
| | - Sandy Preiss
- 6856RTI International, Research Triangle, NC, USA
| | - Emily Hadley
- 6856RTI International, Research Triangle, NC, USA
| | | |
Collapse
|
3
|
Adams JW, Savinkina A, Fox A, Behrends CN, Madushani RWMA, Wang J, Chatterjee A, Walley AY, Barocas JA, Linas BP. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs. Addiction 2022; 117:2635-2648. [PMID: 35315148 PMCID: PMC9951221 DOI: 10.1111/add.15883] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Accepted: 03/06/2022] [Indexed: 12/25/2022]
Abstract
AIM To estimate the number of treatment initiations, averted fatal opioid overdoses and the cost-effectiveness associated with offering buprenorphine-naloxone (buprenorphine) treatment on-site within existing syringe service programs (SSPs) in Massachusetts, USA. DESIGN, SETTING AND PARTICIPANTS This was a cohort-based mathematical model and cost-effectiveness analysis. We derived model inputs from state and national surveillance data, clinical trials and observational cohort studies. We compared an intervention scenario where 30% of SSP clients initiated buprenorphine treatment on-site at least once annually to a status quo scenario where no buprenorphine was available on-site among community treatment providers in Massachusetts, 2020-30. In individuals with opioid use disorder (OUD) we assumed that 80% of SSP clients had recently injected drugs and that treatment within SSPs would have similar or improved retention compared with standard-of-care buprenorphine programs, but higher rates of active opioid use while in treatment. MEASUREMENTS Number of treatment initiations (i.e. individuals began treatment on a medication for opioid use disorder or entered medically managed withdrawal), averted fatal opioid overdoses, quality-adjusted life-years (QALYs) and life-time discounted costs from a health sector and a limited societal perspective. FINDINGS The status quo scenario resulted in 23 051 fatal overdoses and 1 511 613 treatment initiations over a 10-year simulation period. An intervention scenario with on-site SSP buprenorphine treatment averted 4797 (-20.8%) fatal opioid overdoses and resulted in 129 359 (+8.6%) additional treatment initiations compared with the status quo. The intervention scenario was the dominating scenario: providing OUD treatment through Massachusetts SSPs cost less (-$3612 per person) with patients accumulating more QALYs (0.2 per person) compared with the status quo scenario. CONCLUSIONS Offering buprenorphine treatment on-site within syringe service programs has the potential to decrease fatal overdoses substantially, improve treatment engagement and save on costs.
Collapse
Affiliation(s)
- Joëlla W. Adams
- Section of Infectious Diseases, Boston Medical Center (BMC), Boston, MA, USA
- RTI International, Research Triangle, NC, USA
| | - Alexandra Savinkina
- Section of Infectious Diseases, Boston Medical Center (BMC), Boston, MA, USA
| | - Aaron Fox
- Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, USA
| | - Czarina N. Behrends
- Department of Population Health Sciences, Weill Cornell Medical College, New York City, NY, USA
| | | | - Jianing Wang
- Section of Infectious Diseases, Boston Medical Center (BMC), Boston, MA, USA
| | - Avik Chatterjee
- Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA
- Boston University School of Medicine, Boston, MA, USA
| | - Alexander Y. Walley
- Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA
- Boston University School of Medicine, Boston, MA, USA
| | - Joshua A. Barocas
- Divisions of General Internal Medicine and Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA
| | - Benjamin P. Linas
- Section of Infectious Diseases, Boston Medical Center (BMC), Boston, MA, USA
- Boston University School of Medicine, Boston, MA, USA
| |
Collapse
|
4
|
Adams JW, Savinkina A, Hudspeth JC, Gai MJ, Jawa R, Marks LR, Linas BP, Hill A, Flood J, Kimmel S, Barocas JA. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis. JAMA Netw Open 2022; 5:e220541. [PMID: 35226078 PMCID: PMC8886538 DOI: 10.1001/jamanetworkopen.2022.0541] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
IMPORTANCE Emerging evidence supports the use of outpatient parenteral antimicrobial therapy (OPAT) and, in many cases, partial oral antibiotic therapy for the treatment of injection drug use-associated infective endocarditis (IDU-IE); however, long-term outcomes and cost-effectiveness remain unknown. OBJECTIVE To compare the added value of inpatient addiction care services and the cost-effectiveness and clinical outcomes of alternative antibiotic treatment strategies for patients with IDU-IE. DESIGN, SETTING, AND PARTICIPANTS This decision analytical modeling study used a validated microsimulation model to compare antibiotic treatment strategies for patients with IDU-IE. Model inputs were derived from clinical trials and observational cohort studies. The model included all patients with injection opioid drug use (N = 5 million) in the US who were eligible to receive OPAT either in the home or at a postacute care facility. Costs were annually discounted at 3%. Cost-effectiveness was evaluated from a health care sector perspective over a lifetime starting in 2020. Probabilistic sensitivity, scenario, and threshold analyses were performed to address uncertainty. INTERVENTIONS The model simulated 4 treatment strategies: (1) 4 to 6 weeks of inpatient intravenous (IV) antibiotic therapy along with opioid detoxification (usual care strategy), (2) 4 to 6 weeks of inpatient IV antibiotic therapy along with inpatient addiction care services that offered medication for opioid use disorder (usual care/addiction care strategy), (3) 3 weeks of inpatient IV antibiotic therapy along with addiction care services followed by OPAT (OPAT strategy), and (4) 3 weeks of inpatient IV antibiotic therapy along with addiction care services followed by partial oral antibiotic therapy (partial oral antibiotic strategy). MAIN OUTCOMES AND MEASURES Mean percentage of patients completing treatment for IDU-IE, deaths associated with IDU-IE, life expectancy (measured in life-years [LYs]), mean cost per person, and incremental cost-effectiveness ratios (ICERs). RESULTS All modeled scenarios were initialized with 5 million individuals (mean age, 42 years; range, 18-64 years; 70% male) who had a history of injection opioid drug use. The usual care strategy resulted in 18.63 LYs at a cost of $416 570 per person, with 77.6% of hospitalized patients completing treatment. Life expectancy was extended by each alternative strategy. The partial oral antibiotic strategy yielded the highest treatment completion rate (80.3%) compared with the OPAT strategy (78.8%) and the usual care/addiction care strategy (77.6%). The OPAT strategy was the least expensive at $412 150 per person. Compared with the OPAT strategy, the partial oral antibiotic strategy had an ICER of $163 370 per LY. Increasing IDU-IE treatment uptake and decreasing treatment discontinuation made the partial oral antibiotic strategy more cost-effective compared with the OPAT strategy. When assuming that all patients with IDU-IE were eligible to receive partial oral antibiotic therapy, the strategy was cost-saving and resulted in 0.0247 additional discounted LYs. When treatment discontinuation was decreased from 3.30% to 2.65% per week, the partial oral antibiotic strategy was cost-effective compared with OPAT at the $100 000 per LY threshold. CONCLUSIONS AND RELEVANCE In this decision analytical modeling study, incorporation of OPAT or partial oral antibiotic approaches along with addiction care services for the treatment of patients with IDU-IE was associated with increases in the number of people completing treatment, decreases in mortality, and savings in cost compared with the usual care strategy of providing inpatient IV antibiotic therapy alone.
Collapse
Affiliation(s)
- Joëlla W. Adams
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
- RTI International, Research Triangle Park, North Carolina
| | - Alexandra Savinkina
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
| | - James C. Hudspeth
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
| | - Mam Jarra Gai
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
| | - Raagini Jawa
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
- Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
| | - Laura R. Marks
- Division of Infectious Diseases, School of Medicine, Washington University in St Louis, St Louis, Missouri
| | - Benjamin P. Linas
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
- Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
| | - Alison Hill
- Population Health Analytics Division, Boston Medical Center, Boston, Massachusetts
| | - Jason Flood
- Population Health Analytics Division, Boston Medical Center, Boston, Massachusetts
| | - Simeon Kimmel
- Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
- Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
- Section of General Medicine, Boston Medical Center, Boston, Massachusetts
| | - Joshua A. Barocas
- Division of General Internal Medicine, Anschutz Medical Campus, University of Colorado, Aurora
- Division of Infectious Diseases, Anschutz Medical Campus, University of Colorado, Aurora
| |
Collapse
|
5
|
Adams JW, Li Y, Barry DT, Gordon KS, Kerns RD, Oldfield BJ, Rentsch CT, Marshall BDL, Edelman EJ. Long-term Patterns of Self-reported Opioid Use, VACS Index, and Mortality Among People with HIV Engaged in Care. AIDS Behav 2021; 25:2951-2962. [PMID: 33569682 PMCID: PMC8442670 DOI: 10.1007/s10461-021-03162-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/12/2021] [Indexed: 11/28/2022]
Abstract
Longitudinal analyses of opioid use and overall disease severity among people with HIV (PWH) are lacking. We used joint-trajectory and Cox proportional hazard modeling to examine the relationship between self-reported opioid use and the Veterans Aging Cohort Study (VACS) Index 2.0, a validated measure of disease severity and mortality, among PWH engaged in care. Using data from 2002 and 2018, trajectory modeling classified 20% of 3658 PWH in low (i.e., lower risk of mortality), 40% in moderate, 28% in high, and 12% in extremely high VACS Index trajectories. Compared to those with moderate VACS Index trajectory, PWH with an extremely high trajectory were more likely to have high, then de-escalating opioid use (adjusted odds ratio [AOR], 95% confidence interval [CI] 5·17 [3·19-8·37]) versus stable, infrequent use. PWH who report high frequency opioid use have increased disease severity and mortality risk over time, even when frequency of opioid use de-escalates.
Collapse
Affiliation(s)
- Joëlla W Adams
- Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA
| | - Yu Li
- Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA
| | - Declan T Barry
- Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
| | - Kirsha S Gordon
- VA Connecticut Healthcare Systems, West Haven, CT, USA
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
| | - Robert D Kerns
- Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
- VA Connecticut Healthcare Systems, West Haven, CT, USA
| | - Benjamin J Oldfield
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
| | - Christopher T Rentsch
- VA Connecticut Healthcare Systems, West Haven, CT, USA
- Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK
| | - Brandon D L Marshall
- Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA
| | - E Jennifer Edelman
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
- Center for Interdisciplinary Research on AIDS, Yale School of Public Health, 367 Cedar Street, ES Harkness, Suite 401, New Haven, CT, 06510, USA.
| |
Collapse
|
6
|
Adams JW, Khan MR, Bessey S, Friedman SR, McMahon JM, Lurie MN, Galea S, Marshall BD. Preexposure prophylaxis strategies for African-American women affected by mass incarceration. AIDS 2021; 35:453-462. [PMID: 33170818 PMCID: PMC7855567 DOI: 10.1097/qad.0000000000002749] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 09/14/2020] [Accepted: 10/12/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVE We aimed to determine the effectiveness of various preexposure prophylaxis (PrEP) prescription strategies for African-American women impacted by mass incarceration within an urban setting. DESIGN An agent-based model was utilized to evaluate prevention strategies in an efficient, ethical manner. By defining agents, their characteristics and relationships, we assessed population-level effects of PrEP on HIV incidence. METHODS We tested hypothetical PrEP prescription strategies within a simulation representing the African-American population of Philadelphia, Pennsylvania. Four strategies were evaluated: PrEP for women meeting CDC indicators regarding partner characteristics, PrEP for women with a recently incarcerated male partner, PrEP for women with a recently released male partner and couples-based PrEP at time of release. Interventions occurred alongside scale-up of HAART. We evaluated reductions in HIV transmissions, the number of persons on PrEP needed to avert one HIV transmission (NNT) and the resulting proportions of people on PrEP. RESULTS Scenarios prescribing PrEP based on criminal justice system involvement reduced HIV transmissions. The NNT ranged from 147 (couples-based scenario) to 300 (recently released scenario). The percentage of the female population covered by PrEP at any one time ranged from 0.14% (couples-based) to 10.8% (CDC-based). CDC-guideline scenarios were consistently less efficient compared to the justice-involved interventions. CONCLUSION Expanding PrEP for African-American women and their male partners affected by incarceration should be considered in national HIV prevention goals and correctional facilities leveraged as intervention sites. Partner characteristics in the current CDC indications may be more effective and efficient if guidelines considered criminal justice involvement.
Collapse
Affiliation(s)
- Joëlla W. Adams
- Brown University School of Public Health, Providence, Rhode Island
| | - Maria R. Khan
- Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University
| | - S.E. Bessey
- Brown University School of Public Health, Providence, Rhode Island
| | | | | | - Mark N. Lurie
- Brown University School of Public Health, Providence, Rhode Island
| | - Sandro Galea
- Boston University School of Public Health, Boston, Massachusetts, USA
| | | |
Collapse
|
7
|
Macmadu A, Adams JW, Bessey SE, Brinkley-Rubinstein L, Martin RA, Clarke JG, Green TC, Rich JD, Marshall BDL. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study. Int J Drug Policy 2020; 91:102841. [PMID: 32712165 DOI: 10.1016/j.drugpo.2020.102841] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 06/09/2020] [Accepted: 06/11/2020] [Indexed: 11/20/2022]
Abstract
BACKGROUND We examined the impact of expanded access to medications for opioid use disorder (MOUD) in a unified prison and jail system on post-release, opioid-related overdose mortality. METHODS We developed a microsimulation model to simulate a population of 55,000 persons at risk of opioid-related overdose mortality in Rhode Island. The effect of an extended-release (XR) naltrexone only intervention and the effect of providing access to all three MOUD (i.e., methadone, buprenorphine, and XR-naltrexone) at release from incarceration on cumulative overdose death over eight years (2017-2024) were compared to the standard of care (i.e., limited access to MOUD). RESULTS In the standard of care scenario, the model predicted 2385 opioid-related overdose deaths between 2017 and 2024. An XR-naltrexone intervention averted 103 deaths (4.3% reduction), and access to all three MOUD averted 139 deaths (5.8% reduction). Among those with prior year incarceration, an XR-naltrexone only intervention and access to all three MOUD reduced overdose deaths by 22.8% and 31.6%, respectively. CONCLUSIONS Expanded access to MOUD in prison and jail settings can reduce overdose mortality in a general, at-risk population. However, the real-world impact of this approach will vary by levels of incarceration, treatment enrollment, and post-release retention.
Collapse
Affiliation(s)
- Alexandria Macmadu
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA; The Center for Prisoner Health and Human Rights, The Miriam Hospital, 8 Third Street, Providence, RI 02906, USA
| | - Joëlla W Adams
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA
| | - S E Bessey
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA
| | - Lauren Brinkley-Rubinstein
- Department of Social Medicine, University of North Carolina at Chapel Hill, 333 South Columbia Street, Chapel Hill, NC 27516, USA; Center for Health Equity Research, University of North Carolina at Chapel Hill, 335 South Columbia Street, Chapel Hill, NC 27514, USA
| | - Rosemarie A Martin
- Department of Behavioral and Social Science, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA
| | - Jennifer G Clarke
- Rhode Island Department of Corrections, 40 Howard Avenue, Cranston, RI 02920, USA
| | - Traci C Green
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA; Department of Emergency Medicine, The Warren Alpert School of Medicine of Brown University, Rhode Island Hospital, 55 Claverick Street, Providence, RI 02903, USA
| | - Josiah D Rich
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA; The Center for Prisoner Health and Human Rights, The Miriam Hospital, 8 Third Street, Providence, RI 02906, USA
| | - Brandon D L Marshall
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI 02903, USA.
| |
Collapse
|
8
|
Kaufman JS, Banack HR, Adams JW, Marshall BDL, Stovitz SD. Risk Factor Reversal in Studies of Infectious Disease: Making Counterintuitive Results Intuitive Again. Sex Transm Dis 2020; 46:e5-e7. [PMID: 30234795 DOI: 10.1097/olq.0000000000000911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
A previously published study reported the seemingly paradoxical finding that men who have sex with men status was strongly protective and recent sexual abstinence strongly deleterious in relation to mortality prognosis. We explain why these results are entirely logical and that the counterintuitive direction of the effects derives from the comparison group implied by the study design.
Collapse
Affiliation(s)
- Jay S Kaufman
- From the Department of Epidemiology, Biostatistics, and Occupational Health McGill University, Montreal, QC, Canada
| | - Hailey R Banack
- Department of Epidemiology and Environmental Health School of Public Health and Health Professions University at Buffalo, The State University of New York, Buffalo, NY
| | - Joëlla W Adams
- Department of Epidemiology Brown University School of Public Health, Providence, RI, and
| | - Brandon D L Marshall
- Department of Epidemiology Brown University School of Public Health, Providence, RI, and
| | - Steven D Stovitz
- Department of Family Medicine and Community Health University of Minnesota, Minneapolis, MN
| |
Collapse
|
9
|
Macmadu A, Goedel WC, Adams JW, Brinkley-Rubinstein L, Green TC, Clarke JG, Martin RA, Rich JD, Marshall BDL. Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug Alcohol Depend 2020; 208:107858. [PMID: 32050112 PMCID: PMC7075016 DOI: 10.1016/j.drugalcdep.2020.107858] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2019] [Revised: 12/10/2019] [Accepted: 01/03/2020] [Indexed: 11/20/2022]
Abstract
BACKGROUND Medications for opioid use disorder (OUD) are the most effective treatment for OUD, but uptake of these life-saving medications has been extremely limited in US prisons and jail settings, and limited data are available to guide policy decisions. The objective of this study was to estimate the impact of screening and treatment with medications for OUD in US prisons and jails on post-release opioid-related mortality. METHODS We used data from the National Center for Vital Statistics, the Bureau of Justice Statistics, and relevant literature to construct Monte Carlo simulations of a counterfactual scenario in which wide scale uptake of screening and treatment with medications for OUD occurred in US prisons and jails in 2016. RESULTS Our model predicted that 1840 (95% Simulation Interval [SI]: -2757 - 4959) lives would have been saved nationally if all persons who were clinically indicated had received medications for OUD while incarcerated. The model also predicted that approximately 4400 (95% SI: 2675 - 5557) lives would have been saved nationally if all persons who were clinically indicated had received medications for OUD while incarcerated and were retained in treatment post-release. These estimates correspond to 668 (95% SI: -1008 - 1812) and 1609 (95% SI: 972 - 2037) lives saved per 10,000 persons incarcerated, respectively. CONCLUSIONS Prison and jail-based programs that comprehensively screen and provide treatment with medications for OUD have the potential to produce substantial reductions in opioid-related overdose deaths in a high-risk population; however, retention on treatment post-release is a key driver of population level impact.
Collapse
Affiliation(s)
- Alexandria Macmadu
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, USA; The Center for Prisoner Health and Human Rights, The Miriam Hospital, 8 Third Street, Providence, RI, USA
| | - William C Goedel
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, USA
| | - Joëlla W Adams
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, USA
| | - Lauren Brinkley-Rubinstein
- Department of Social Medicine, University of North Carolina at Chapel Hill, 333 South Columbia Street, Chapel Hill, NC, 27516, USA; Center for Health Equity Research, University of North Carolina at Chapel Hill, 335 South Columbia Street, Chapel Hill, NC, 27514, USA
| | - Traci C Green
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, USA; Department of Emergency Medicine, Boston University Medical Center, 725 Albany Street, Boston, MA, 02118, USA
| | - Jennifer G Clarke
- Rhode Island Department of Corrections, 40 Howard Avenue, Cranston, RI, 02920, USA
| | - Rosemarie A Martin
- Department of Behavioral and Social Science, Brown University, 121 South Main Street, Providence, RI 02903, USA
| | - Josiah D Rich
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, USA; The Center for Prisoner Health and Human Rights, The Miriam Hospital, 8 Third Street, Providence, RI, USA
| | - Brandon D L Marshall
- Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Providence, RI, USA.
| |
Collapse
|
10
|
Zullo AR, Adams JW, Gantenberg JR, Marshall BDL, Howe CJ. Examining neighborhood poverty-based disparities in HIV/STI prevalence: an analysis of Add Health data. Ann Epidemiol 2019; 39:8-14.e4. [PMID: 31679893 DOI: 10.1016/j.annepidem.2019.09.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 09/12/2019] [Accepted: 09/23/2019] [Indexed: 12/27/2022]
Abstract
PURPOSE The purpose of the study was to estimate the effect of exposure to neighborhood poverty in adolescence on HIV/STI prevalence in early adulthood. METHODS Longitudinal data from three waves of the National Longitudinal Study of Adolescent to Adult Health were analyzed. The primary exposure was living in a high- versus medium/low-poverty neighborhood during wave I. The outcome was having a sexually transmitted infection (STI) or receiving a HIV/STI diagnosis in the past 12 months at wave III. Covariates included sociodemographic, behavioral, and mental health-related factors. Inverse probability weighted marginal structural models were used to estimate neighborhood poverty-based differences in HIV/STI prevalence. RESULTS The analytic sample comprised 8232 National Longitudinal Study of Adolescent to Adult Health participants. Of these, 16% and 84% resided in high- and medium/low-poverty neighborhoods, respectively. Eleven percent currently had an STI or HIV/STI diagnosis within the prior 12 months. Accounting for measured potential sources of confounding and selection bias, the HIV/STI prevalence difference (95% confidence limits) for those who grew up in high- versus medium/low-poverty neighborhoods was 0.015 (-0.015, 0.045). CONCLUSIONS Strong evidence for neighborhood poverty-based differences in HIV/STI prevalence was not observed. Researchers should continue to investigate the effect of neighborhood-level socioeconomic position measures and, if warranted, identify etiologically relevant exposure periods.
Collapse
Affiliation(s)
- Andrew R Zullo
- Departments of Health Services, Policy, and Practice and Epidemiology, Brown University School of Public Health, Centers for Evidence Synthesis and Gerontology and Healthcare Research, Providence, RI; Providence Veterans Affairs Medical Center, Center of Innovation in Long-Term Services and Supports, Providence, RI.
| | - Joëlla W Adams
- Department of Epidemiology, Brown University School of Public Health, Centers for Epidemiology and Environmental Health, Providence, RI
| | - Jason R Gantenberg
- Department of Epidemiology, Brown University School of Public Health, Centers for Epidemiology and Environmental Health, Providence, RI
| | - Brandon D L Marshall
- Department of Epidemiology, Brown University School of Public Health, Centers for Epidemiology and Environmental Health, Providence, RI
| | - Chanelle J Howe
- Department of Epidemiology, Brown University School of Public Health, Centers for Epidemiology and Environmental Health, Providence, RI
| |
Collapse
|
11
|
Adams JW, Lurie MN, King MRF, Brady KA, Galea S, Friedman SR, Khan MR, Marshall BDL. Decreasing HIV transmissions to African American women through interventions for men living with HIV post-incarceration: An agent-based modeling study. PLoS One 2019; 14:e0219361. [PMID: 31306464 PMCID: PMC6629075 DOI: 10.1371/journal.pone.0219361] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2018] [Accepted: 06/21/2019] [Indexed: 11/18/2022] Open
Abstract
Background Incarceration and HIV disproportionately impact African American communities. The mass incarceration of African American men is hypothesized to increase HIV acquisition risk for African American women. Interventions optimizing HIV care engagement and minimizing sexual risk behaviors for men living with HIV post-incarceration may decrease HIV incidence. Methods Using an agent-based model, we simulated a sexual and injection drug using network representing the African American population of Philadelphia. We compared intervention strategies for men living with HIV post-incarceration by the number of averted HIV transmissions to women within the community. Three interventions were evaluated: a 90-90-90 scenario scaling up HIV testing, ART provision, and ART adherence; a behavioral intervention decreasing sexual risk behaviors; and a combination intervention involving both. Results The status quo scenario projected 2,836 HIV transmissions to women over twenty years. HIV transmissions to women decreased by 29% with the 90-90-90 intervention, 23% with the behavioral intervention, and 37% with both. The number of men living with HIV receiving the intervention needed in order to prevent a single HIV transmission ranged between 6 and 10. Conclusion Interventions to improve care engagement and decrease sexual risk behaviors post-incarceration for men living with HIV have the potential to decrease HIV incidence within African American heterosexual networks.
Collapse
Affiliation(s)
- Joëlla W. Adams
- Brown University School of Public Health, Providence, Rhode Island, United States of America
| | - Mark N. Lurie
- Brown University School of Public Health, Providence, Rhode Island, United States of America
| | - Maximilian R. F. King
- Brown University School of Public Health, Providence, Rhode Island, United States of America
| | - Kathleen A. Brady
- AIDS Activities Coordinating Office, Philadelphia Department of Public Health, Philadelphia, Pennsylvania, United States of America
| | - Sandro Galea
- Boston University School of Public Health, Boston, Massachusetts, United States of America
| | - Samuel R. Friedman
- National Development and Research Institutes, New York City, New York, United States of America
| | - Maria R. Khan
- Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University, New York City, New York, United States of America
| | - Brandon D. L. Marshall
- Brown University School of Public Health, Providence, Rhode Island, United States of America
- * E-mail:
| |
Collapse
|
12
|
Adams JW, Lurie MN, King MRF, Brady KA, Galea S, Friedman SR, Khan MR, Marshall BDL. Potential drivers of HIV acquisition in African-American women related to mass incarceration: an agent-based modelling study. BMC Public Health 2018; 18:1387. [PMID: 30563496 PMCID: PMC6299641 DOI: 10.1186/s12889-018-6304-x] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2018] [Accepted: 12/05/2018] [Indexed: 02/06/2023] Open
Abstract
Background The United States has the highest incarceration rate in the world. Incarceration can increase HIV risk behaviors for individuals involved with the criminal justice system and may be a driver of HIV acquisition within the community. Methods We used an agent-based model to simulate HIV transmission in a sexual-contact network representing heterosexual African American men and women in Philadelphia to identify factors influencing the impact of male mass incarceration on HIV acquisition in women. The model was calibrated using surveillance data and assumed incarceration increased the number of sexual contacts and decreased HIV care engagement for men post-release. Incarceration of a partner increased the number of sexual contacts for women. We compared a counterfactual scenario with no incarceration to scenarios varying key parameters to determine what factors drove HIV acquisition in women. Results Setting the duration of male high-risk sexual behavior to two years post-release increased the number of HIV transmissions to women by more than 20%. Decreasing post-release HIV care engagement and increasing HIV acquisition risk attributable to sexually transmitted infections (STIs) also increased the number of HIV transmissions to women. Changing the duration of risk behavior for women, the proportion of women engaging in higher risk behavior, and the relative risk of incarceration for HIV-infected men had minimal impact. Conclusion The mass incarceration of African American men can increase HIV acquisition in African American women on a population-level through factors including post-release high-risk behaviors, disruption of HIV care engagement among formerly incarcerated men, and increased STI prevalence. These findings suggest that the most influential points of intervention may be programs seeking to reduce male risk behaviors and promote HIV care engagement post-release, as well as STI testing and treatment programs for recently incarcerated men, as well as women with incarcerated partners. Electronic supplementary material The online version of this article (10.1186/s12889-018-6304-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Joëlla W Adams
- Brown University School of Public Health, 121 South Main Street, Providence, RI, 02912, USA
| | - Mark N Lurie
- Brown University School of Public Health, 121 South Main Street, Providence, RI, 02912, USA
| | - Maximilian R F King
- Brown University School of Public Health, 121 South Main Street, Providence, RI, 02912, USA
| | - Kathleen A Brady
- Philadelphia Department of Public Health, AIDS Activities Coordinating Office, Philadelphia, PA, USA
| | - Sandro Galea
- Boston University School of Public Health, Boston, MA, USA
| | - Samuel R Friedman
- National Development and Research Institutes, New York City, NY, USA
| | - Maria R Khan
- Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University, New York City, NY, USA
| | - Brandon D L Marshall
- Brown University School of Public Health, 121 South Main Street, Providence, RI, 02912, USA.
| |
Collapse
|
13
|
Adams JW, Bryant KJ, Edelman EJ, Fiellin DA, Gaither JR, Gordon AJ, Gordon KS, Kraemer KL, Mimiaga MJ, Operario D, Tate JP, van den Berg JJ, Justice AC, Marshall BDL. Correction to: Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. AIDS Behav 2018. [PMID: 29520509 DOI: 10.1007/s10461-018-2075-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
In the original publication of the article, the given and family name of the third author was not correct. The name has been corrected with this erratum.
Collapse
|
14
|
Adams JW, Bryant KJ, Edelman EJ, Fiellin DA, Gaither JR, Gordon AJ, Gordon KS, Kraemer KL, Mimiaga MJ, Operario D, Tate JP, van den Berg JJ, Justice AC, Marshall BDL. Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. AIDS Behav 2018; 22:1341-1351. [PMID: 28887669 DOI: 10.1007/s10461-017-1905-4] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Questionnaires over a 9-year study period (2002-2010) were used to characterize cannabis, stimulant, and alcohol use among 3099 HIV-infected men participating in the Veterans Aging Cohort Study (VACS) to determine whether use of these substances is associated with changes in the VACS Index, a validated prognostic indicator for all-cause mortality. At baseline, 18% of participants reported no substance use in the past year, 24% lower risk alcohol use only, 18% unhealthy alcohol use only, 15% cannabis use (with or without alcohol), and 24% stimulant use (with or without alcohol or cannabis). In adjusted longitudinal analyses, cannabis use [β = -0.97 (95% CI -1.93, 0.00), p = 0.048] was not associated with mortality risk, while stimulant use [1.08 (0.16, 2.00), p = 0.021] was associated with an increased mortality risk, compared to lower risk alcohol use. Our findings show no evidence of a negative effect of cannabis use on mortality risk, while stimulant use was associated with increased mortality risk among HIV-infected men. Interventions to reduce stimulant use in this patient population may reduce mortality.
Collapse
Affiliation(s)
- Joëlla W Adams
- Brown University School of Public Health, Providence, RI, USA
| | - Kendall J Bryant
- National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, USA
| | - E Jennifer Edelman
- Division of General Internal Medicine and the Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA
| | - David A Fiellin
- Division of General Internal Medicine and the Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA
| | - Julie R Gaither
- Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA
| | - Adam J Gordon
- Center for Health Equity Research and Promotion, Pittsburgh VA Healthcare System, Pittsburgh, PA, USA
- Division of General Internal Medicine, Department of Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA
| | - Kirsha S Gordon
- Veterans Aging Cohort Study Coordinating Center, Veterans Administration Connecticut Healthcare System, West Haven, CT, USA
| | | | | | - Don Operario
- Brown University School of Public Health, Providence, RI, USA
| | - Janet P Tate
- Division of General Internal Medicine and the Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA
- Veterans Aging Cohort Study Coordinating Center, Veterans Administration Connecticut Healthcare System, West Haven, CT, USA
| | | | - Amy C Justice
- Division of General Internal Medicine and the Center for Interdisciplinary Research on AIDS, Yale University School of Medicine, New Haven, CT, USA
- Veterans Aging Cohort Study Coordinating Center, Veterans Administration Connecticut Healthcare System, West Haven, CT, USA
| | | |
Collapse
|
15
|
Adams JW, Shinefeld J, Brady KA. Acceptability of Oral Preexposure Prophylaxis Among Men Who Have Sex With Men in Philadelphia. J Acquir Immune Defic Syndr 2018; 73:e62-e65. [PMID: 27454249 DOI: 10.1097/qai.0000000000001139] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Joëlla W Adams
- *AIDS Activities Coordinating Office, Philadelphia Department of Public Health, Philadelphia, PA †Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| | | | | |
Collapse
|
16
|
Adams JW, Howe CJ, Andrews AC, Allen SL, Vinnard C. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay. AIDS Care 2017; 29:1504-1509. [PMID: 28486818 DOI: 10.1080/09540121.2017.1325438] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
National guidelines recommend screening for latent tuberculosis infection (LTBI) in all HIV-infected patients. Thus, the objective of this study was to measure protocol adherence to national guidelines regarding LTBI screening for HIV-infected patients entering care at an urban primary care clinic specializing in HIV care, identify clinical and other characteristics associated with adherence, and determine whether transitioning from the tuberculin skin test (TST) to the interferon-gamma release assay (IGRA) improved adherence. We conducted a retrospective study using protocol adherence to LTBI screening guidelines within twelve months of entering care at an HIV clinic as the primary outcome. Successful protocol adherence was defined as the placement and reading of a TST, performance of an IGRA, or a note in study clinic records documenting prior testing or treatment for tuberculosis in an outside setting. Multivariable modified Poisson regression models were used in analyses. Overall, 32% (n = 118/372) of patients received LTBI screening within twelve months of entering care. Protocol adherence to LTBI screening guidelines increased from 28% to 37% following the transition from TST to IGRA screening. IGRA screening [adjusted prevalence ratio: 1.45, 95% confidence limits: (1.07, 1.96)], male sex [1.47 (1.05, 2.07)], transfer patient status [1.51 (1.05, 2.18)], and greater than one year of clinic attendance [1.62 (1.06, 2.48)] were independently associated with protocol adherence. Among patients without prior LTBI screening or treatment, patients entering the clinic in 2013 under the IGRA screening protocol were more likely to be screened for LTBI compared to patients entering under the TST screening protocol (34.3% vs. 9.7%, p < 0.001). In conclusion, transitioning from TST to IGRA-based screening improved adherence to screening guidelines. However, further work on improving adherence to LTBI screening guidelines among HIV-infected patients is needed.
Collapse
Affiliation(s)
- J W Adams
- a Department of Epidemiology , Brown University School of Public Health , Providence , USA
| | - C J Howe
- a Department of Epidemiology , Brown University School of Public Health , Providence , USA
| | - A C Andrews
- b Department of Epidemiology , Drexel School of Public Health , Philadelphia , PA , USA
| | - S L Allen
- c Division of Infectious Diseases & HIV Medicine , Drexel University College of Medicine , Philadelphia , PA , USA
| | - C Vinnard
- d Public Health Research Institute, Rutgers , The State University of New Jersey , Newark , NJ , USA
| |
Collapse
|
17
|
Adams JW, Watts DH, Phelps BR. A systematic review of the effect of HIV infection and antiretroviral therapy on the risk of pre-eclampsia. Int J Gynaecol Obstet 2015; 133:17-21. [PMID: 26797203 DOI: 10.1016/j.ijgo.2015.08.007] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2015] [Revised: 07/24/2015] [Accepted: 11/27/2015] [Indexed: 01/01/2023]
Abstract
BACKGROUND The associations between HIV infection, antiretroviral therapy (ART), and pre-eclampsia are unclear. OBJECTIVES To summarize research and clarify the implications of HIV and ART on pre-eclampsia risk. SEARCH STRATEGY MedLine, PubMed, Web of Science, and the Cochrane Library were searched for studies published between 2003 and July 2014, using relevant keywords. SELECTION CRITERIA Full-text review was dependent on the inclusion of pre-eclampsia as an outcome and original data. DATA COLLECTION AND ANALYSIS Data for population, confounders, limitations, and measures of association were qualitatively assessed. MAIN RESULTS Among 550 records identified, 70 were screened, and 13 were included. Five of the nine studies comparing pre-eclampsia risk between women with and without HIV infection found no significant difference; only one found that women living with HIV were more likely to experience pre-eclampsia. Two studies found that women living with HIV who were receiving ART at conception were more likely to experience pre-eclampsia than were those not receiving ART at conception. Two studies reported that pre-eclampsia rates did not differ by ART regimen. CONCLUSIONS There is insufficient evidence to conclude that women living with HIV and receiving ART have a higher risk of pre-eclampsia than do women without HIV infection; further research is needed to assess the association between ART and pre-eclampsia.
Collapse
Affiliation(s)
- Joëlla W Adams
- United States Agency for International Development, Washington, DC, USA.
| | - D Heather Watts
- Pediatric, Adolescent, and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, MD, USA
| | - B Ryan Phelps
- United States Agency for International Development, Washington, DC, USA
| |
Collapse
|
18
|
Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum Engagement in HIV Care: An Important Predictor of Long-term Retention in Care and Viral Suppression. Clin Infect Dis 2015; 61:1880-7. [DOI: 10.1093/cid/civ678] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2015] [Accepted: 07/28/2015] [Indexed: 01/21/2023] Open
|
19
|
Yardley DA, Kaufman PA, Adams JW, Krekow L, Savin M, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Huang W, Weidler J, Lie Y, Paquet A, Haddad M, Anderson S, Brigino M, Bosserman L. Abstract P2-05-06: Quantitative measurement of HER2 expression in breast cancers: comparison with “real world” HER2 testing in a multi-center Collaborative Biomarker Study (CBS) and correlation with clinicopathological features. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p2-05-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Accurate determination of HER2 status is critical in determining appropriate therapy for breast cancer patients. The HERmark® assay is a novel method to quantitatively measure HER2 total protein expression (H2T) in breast cancer. In this study, we compared HERmark H2T with central laboratory HER2 retesting and local (site reported) HER2 testing of formalin-fixed, paraffin-embedded (FFPE) breast cancer tissues. The quantitative total HER2 measurements (H2T) by HERmark and results of local HER2 tests were correlated with tumor pathohistological characteristics and overall survival of breast cancer patients.
Methods: 232 FFPE breast cancer tissues were provided by 11 CBS study sites for HER2 testing by the HERmark assay and central laboratory IHC re-testing performed in blinded fashion. Local HER2 immunohistochemistry and/or fluorescence in situ hybridization (FISH) results and valid HERmark H2T and central HER2 IHC results were obtained in 192 cases for analysis.
Results: H2T showed a significant correlation with central HER2 IHC staining intensity (P < 0.0001). The concordance rates of positive and negative HERmark status (excluding equivocal) with those of local HER2 status determined by the CBS sites, and with those of central HER2 IHC status were 84% (Kappa = 0.68) and 96% (Kappa = 0.91), respectively. Higher H2T levels significantly correlated with higher tumor grade (p = 0.007) and negative ER/PR status (p = 0.002). Twenty-six (14%) cases showed discordant (conversion of negative and positive) results between local HER2 status and HERmark status. Of the discordant cases, HERmark significantly agreed with H-score of central HER2 IHC retesting (p = 0.014), as compared with local HER2 status. The concordant negative group (local HER2 negative/H2T low) demonstrated better overall survival (OS) (HR = 0.198, p = 0.0001), compared to that of concordant positive group (local HER2 positive/H2T high). The concordant negative group also showed better OS than that of discordant local HER2 negative/H2T high group (HR = 0.065, p = 0.0003), but showed no significant difference in OS as compared to that of discordant local HER2 positive/H2T low group (HR = 1.774, p = 0.499).). In 24 cases (13%) considered to be “triple negative” by local HER2, ER and PR testing, HERmark re-classified 4 cases (17%) as HER2 positive.
Conclusions: H2T by HERmark yields a continuum of quantitative HER2 protein measurements that shows an excellent correlation with central HER2 IHC retesting and confirms the known correlations between HER2 expression with tumor grade and ER/PR status. OS results of concordant HER2 positive or negative groups (between local HER2 testing and HERmark H2T) confirmed that HER2 positive patients (excluding adjuvant trastuzumab therapy) have worse OS than patients with HER2 negative disease. However, in the HERmark and local HER2 discordant groups, OS appeared to track better with H2T by HERmark and not with the local HER2 status. Novel quantitative HER2 measurements may identify patients with false (+) and (−) HER2 status by local HER2 testing and may provide added clinical value to routine “real world” HER2 testing.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P2-05-06.
Collapse
Affiliation(s)
- DA Yardley
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - PA Kaufman
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - JW Adams
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - L Krekow
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - M Savin
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - WE Lawler
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - S Zrada
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - A Starr
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - H Einhorn
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - LS Schwartzberg
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - W Huang
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - J Weidler
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - Y Lie
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - A Paquet
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - M Haddad
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - S Anderson
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - M Brigino
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| | - L Bosserman
- Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology PLLC, Nashville, TN; Dartmouth Hitchcock Medical Center, Lebanon, NH; Arlington Cancer Center, Arlington, TX; Texas Oncology Bedford, Bedford, TX; Texas Oncology at Medical City Dallas 2, Dallas, TX; St. Jude Heritage Medical Group, Fullerton, CA; The Center for Cancer and Hematologic Disease, Cherry Hill, NJ; Monroe Medical Associates, Harvey, IL; Swedish American Regional Cancer Center, Rockford, IL; The West Clinic, Memphis, TN; Monogram Biosciences, Inc., So. San Francisco, CA; Center for Molecular Biology and Pathology, Laboratory Corporation of America, Inc., Research Triangle Park, NC; Wilshire Oncology Medical Group, Rancho Cucamonga, CA
| |
Collapse
|
20
|
Braban CF, Adams JW, Rodriguez D, Cox RA, Crowley JN, Schuster G. Heterogeneous reactions of HOI, ICl and IBr on sea salt and sea salt proxies. Phys Chem Chem Phys 2007; 9:3136-48. [PMID: 17612737 DOI: 10.1039/b700829e] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
The heterogeneous chemistry of HOI, ICl and IBr on sea salt and sea salt proxies has been studied at 274 K using two experimental approaches: a wetted wall flow tube coupled to an electron impact mass spectrometer (WWFT-MS) and an aerosol flow tube (AFT) coupled to a differential mobility analyser (DMA) and a chemical ionisation mass spectrometer (CIMS). Uptake of all three title molecules into bulk aqueous halide salt films was rapid and controlled by gas phase diffusion. Uptake of HOI gave rise to gas-phase ICl and IBr, with the latter being the predominant product whenever Br(-) was present. Only partial release of IBr was observed due to high solubility of dihalogens in the film. ICl uptake gave the same yield of IBr as HOI uptake. Uptake of ICl on NaBr aerosol was accommodation limited with alpha = 0.018 +/- 0.004 and gas phase IBr product has a yield of 0.6 +/- 0.3. The results show that HOI can act as a catalyst for activation of bromine from sea-salt aerosols in the marine boundary layer, via the reactions: HOI(aq) + Cl + H--> ICl(aq) + H(2)O(l) and ICl(aq) + Br--> IBr(aq) + Cl.
Collapse
Affiliation(s)
- C F Braban
- Department of Chemistry, University of Cambridge, Lensfield Rd, Cambridge, UK
| | | | | | | | | | | |
Collapse
|
21
|
Abstract
Elemental mercury, contaminated with radionuclides, presents a waste disposal problem throughout the Department of Energy complex. In this paper we describe a new process to immobilize elemental mercury wastes, including those contaminated with radionuclides, in a form that is non-dispersible, will meet EPA leaching criteria, and has low mercury vapor pressure. In this stabilization and solidification process, elemental mercury is combined with an excess of powdered sulfur polymer cement (SPC) and sulfide additives in a mixing vessel and heated to approximately 40 degrees C for several hours, until all of the mercury is converted into mercuric sulfide (HgS). Additional SPC is then added and the temperature of the mixture raised to 135 degrees C, resulting in a molten liquid which is poured into a mold where it cools and solidifies. The final treated waste was characterized by powder X-ray diffraction and found to be a mixture of the hexagonal and orthorhombic forms of mercuric sulfide. The Toxicity Characteristic Leaching Procedure was used to assess mercury releases, which for the optimized process averaged 25.8 microg/l, with some samples being well below the new EPA Universal Treatment Standard of 25 microg/l. Longer term leach tests were also conducted, indicating that the leaching process was dominated by diffusion. Values for the effective diffusion coefficient averaged 7.6x10(-18) cm2/s. Concentrations of mercury vapor from treated waste in equilibrium static headspace tests averaged 0.6 mg/m3.
Collapse
Affiliation(s)
- M Fuhrmann
- Environmental Research & Technology Division, Environmental Sciences Department, Brookhaven National Laboratory, Upton, NY 11973-5000, USA.
| | | | | | | | | |
Collapse
|
22
|
Snowling MJ, Adams JW, Bishop DV, Stothard SE. Educational attainments of school leavers with a preschool history of speech-language impairments. Int J Lang Commun Disord 2001; 36:173-183. [PMID: 11344593 DOI: 10.1080/13682820010019892] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
This paper reports a follow-up study of a cohort of 16- and 17-year-olds with a preschool history of speech-language impairment and whom Bishop and Edmundson (1987) originally studied. Information collected by questionnaire showed that the GCSE grades of those whose language impairments had resolved by 5;06 were below those of age-matched controls. However, the number of GCSE examinations entered and passed was significantly more than those of the 'persistent S-LI' and 'general delay' groups. Overall, IQ was the strongest predictor of educational attainment. However, even when IQ was controlled, literacy skills accounted for independent variance in achievement, especially among those with a history of language difficulty. The survey also noted that the majority of students across all groups remained in full-time education; however, the adolescents with a background of S-LI were more likely to follow vocational and employment training courses rather than A-levels.
Collapse
Affiliation(s)
- M J Snowling
- Department of Psychology, Heslington Road, University of York, York YO10 5DD, UK.
| | | | | | | |
Collapse
|
23
|
Abstract
The acute contractile function of the heart is controlled by the effects of released nonepinephrine (NE) on cardiac adrenergic receptors. NE can also act in a more chronic fashion to induce cardiomyocyte growth, characterized by cell enlargement (hypertrophy), increased protein synthesis, alterations in gene expression and addition of sarcomeres. These responses enhance cardiomyocyte contractile function and thus allow the heart to compensate for increased stress. The hypertrophic effects of NE are mediated through Gq-coupled alpha(1)-adrenergic receptors and are mimicked by the actions of other neurohormones (endothelin, prostaglandin F(2alpha) angiotensin II) that also act on Gq-coupled receptors. Activation of phospholipase C by Gq is necessary for these responses, and protein kinase C and MAP kinases have also been implicated. Gq stimulated cardiac hypertrophy is also evident in transgenic mouse models. In contrast, stimulation of G(s)-coupled beta-adrenergic receptors or G(i)-coupled receptors do not directly effect cardiomyocyte hypertrophy. Apoptosis is also induced by G-protein-coupled receptor stimulation in cardiomyocytes. Sustained or excessive activation of either Gq- or Gs-signaling pathways results in apoptotic loss of cardiomyocytes both in vitro and in vivo. Apoptosis is associated with decreased ventricular function in the failing heart. Cardiomyocytes provide an ideal model system for understanding the basis for G-protein mediated hypertrophy and apoptosis, and the mechanisms responsible for the transition from compensatory to deleterious levels of signaling. This information may prove critical for designing interventions that prevent the pathophysiological consequences of heart failure.
Collapse
Affiliation(s)
- J W Adams
- University of California, San Diego, Department of Pharmacology, 9500 Gilman Drive, 0636, La Jolla, CA 92093-0636, USA
| | | |
Collapse
|
24
|
Adams JW, Pagel AL, Means CK, Oksenberg D, Armstrong RC, Brown JH. Cardiomyocyte apoptosis induced by Galphaq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res 2000; 87:1180-7. [PMID: 11110776 DOI: 10.1161/01.res.87.12.1180] [Citation(s) in RCA: 81] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Expression of the wild-type alpha subunit of Gq stimulates phospholipase C and induces hypertrophy in cardiomyocytes. Addition of Gq-coupled receptor agonists additionally activates phospholipase C, as does expression of a constitutively active mutant form of Galphaq. Under these conditions, hypertrophy is rapidly succeeded by apoptotic cellular and molecular changes, including myofilament disorganization, loss of mitochondrial membrane potential, alterations in Bcl-2 family protein levels, DNA fragmentation, increased caspase activity ( approximately 4-fold), cytochrome c redistribution, and nuclear chromatin condensation in approximately 12% of the cells. We used various interventions to define the molecular relationships between these events and identify potential sites at which these features of apoptosis could be rescued. Treatment with caspase inhibitors prevented DNA fragmentation and promoted myocyte survival; however, cytochrome c release and loss of mitochondrial membrane potential still occurred. In contrast, treatment with bongkrekic acid, an inhibitor of the mitochondrial permeability transition pore, not only prevented DNA fragmentation and reduced nuclear chromatin condensation but also preserved mitochondrial membrane potential and limited cytochrome c redistribution to only approximately 2% of cells. These data demonstrate the central role of mitochondrial membrane potential in initiation of caspase activation and downstream apoptotic events and suggest that preservation of mitochondrial integrity is crucial for prolonging the life and function of cardiomyocytes exposed to pathological levels of stress.
Collapse
Affiliation(s)
- J W Adams
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, USA
| | | | | | | | | | | |
Collapse
|
25
|
Bucur SZ, Gillespie TW, Lee ME, Adams JW, Bray RA, Villinger F, Ansari AA, Hillyer CD. Hematopoietic response to lineage-non-specific (rrIL-3) and lineage-specific (rhG-CSF, rhEpo, rhTpo) cytokine administration in SIV-infected rhesus macaques is related to stage of infection. J Med Primatol 2000; 29:47-56. [PMID: 10950451 DOI: 10.1034/j.1600-0684.2000.290201.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The present study reports the hematopoietic response to the exogenous administration of recombinant rhesus interleukin-3 (rrIL-3) or a combination of recombinant human granulocyte colony-stimulating factor (rhG-CSF)/erythropoietin (Epo)/thrombopoietin (Tpo) at two different stages of SIV infection: Early-stage (n = 6, CD4 + > 1000/microl and mild splenomegaly) and late-stage (n = 6, CD4 + < 500/microl, progressive hepatosplenomegaly and/or weight loss). SIV-infected animals exhibited significantly impaired bone marrow (BM) and peripheral blood (PB) responses to both rrIL-3 and rhG-CSF/Epo/Tpo administration, as compared to historic controls. In addition, compared to early-stage SIV-infected animals, late-stage SIV-infected macaques demonstrated a more marked dysfunction, as assessed by PB and BM CD34 + content and clonogenic progenitors (colony-forming unit). Neither rrIL-3 nor rhG-CSF/Epo/Tpo administration during either early-stage or late-stage SIV infection increased the viral load, as assessed by bDNA assay. These data suggest that hematopoietic reserve and the response to various cytokines is decreased even in early-stage SIV infection, with the hematopoietic dysfunction progressing in parallel to SIV infection.
Collapse
Affiliation(s)
- S Z Bucur
- Department of Pathology, Regional Primate Research Center, Emory University, Atlanta, GA 30322, USA
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Kasakoff AB, Adams JW. The effects of migration, place, and occupation on adult mortality in the American north, 1740-1880. Hist Methods 2000; 33:115-30. [PMID: 17607877 DOI: 10.1080/01615440009598954] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
|
27
|
Adams JW, Snowling MJ, Hennessy SM, Kind P. Problems of behaviour, reading and arithmetic: assessments of comorbidity using the Strengths and Difficulties Questionnaire. Br J Educ Psychol 1999; 69 ( Pt 4):571-85. [PMID: 10665170 DOI: 10.1348/000709999157905] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
BACKGROUND Estimates of academic underachievement among school children vary widely, depending on the geographical location and on the criteria used to define attainment. AIM To examine the relationship between behaviour problems and academic attainment in a large UK primary school. METHOD A school population (364 children from Years 3 to 6 inclusive) were assessed on a range of cognitive ability tasks. These included standardised tests of reading, arithmetic and verbal and non-verbal intelligence. Under-achievement was assessed using different criteria. To assess behaviour, teachers completed the Strengths and Difficulties Questionnaire (Goodman, 1997) for each participating child. Finally, academic progress of a subset of children was assessed after one year. RESULTS Indicated a significant relationship between behaviour and academic attainment; prosocial behaviour was positively correlated with reading and arithmetic, hyperactivity and conduct problems were negatively correlated. This association was especially strong in the children rated by the questionnaire as hyperactive, where around 1 in 5 had a specific reading deficit. However, there was no evidence to indicate that children with behaviour problems made less academic progress over a one-year period relative to their peers. CONCLUSION The study highlights the importance of assessing both cognitive skills and behaviour, particularly when planning the educational management of children with reading difficulties.
Collapse
Affiliation(s)
- J W Adams
- Psychology Department, University of York, Heslington, UK.
| | | | | | | |
Collapse
|
28
|
Imamura T, Vollenweider P, Egawa K, Clodi M, Ishibashi K, Nakashima N, Ugi S, Adams JW, Brown JH, Olefsky JM. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol 1999; 19:6765-74. [PMID: 10490615 PMCID: PMC84673 DOI: 10.1128/mcb.19.10.6765] [Citation(s) in RCA: 118] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We evaluated the role of the G alpha-q (Galphaq) subunit of heterotrimeric G proteins in the insulin signaling pathway leading to GLUT4 translocation. We inhibited endogenous Galphaq function by single cell microinjection of anti-Galphaq/11 antibody or RGS2 protein (a GAP protein for Galphaq), followed by immunostaining to assess GLUT4 translocation in 3T3-L1 adipocytes. Galphaq/11 antibody and RGS2 inhibited insulin-induced GLUT4 translocation by 60 or 75%, respectively, indicating that activated Galphaq is important for insulin-induced glucose transport. We then assessed the effect of overexpressing wild-type Galphaq (WT-Galphaq) or a constitutively active Galphaq mutant (Q209L-Galphaq) by using an adenovirus expression vector. In the basal state, Q209L-Galphaq expression stimulated 2-deoxy-D-glucose uptake and GLUT4 translocation to 70% of the maximal insulin effect. This effect of Q209L-Galphaq was inhibited by wortmannin, suggesting that it is phosphatidylinositol 3-kinase (PI3-kinase) dependent. We further show that Q209L-Galphaq stimulates PI3-kinase activity in p110alpha and p110gamma immunoprecipitates by 3- and 8-fold, respectively, whereas insulin stimulates this activity mostly in p110alpha by 10-fold. Nevertheless, only microinjection of anti-p110alpha (and not p110gamma) antibody inhibited both insulin- and Q209L-Galphaq-induced GLUT4 translocation, suggesting that the metabolic effects induced by Q209L-Galphaq are dependent on the p110alpha subunit of PI3-kinase. In summary, (i) Galphaq appears to play a necessary role in insulin-stimulated glucose transport, (ii) Galphaq action in the insulin signaling pathway is upstream of and dependent upon PI3-kinase, and (iii) Galphaq can transmit signals from the insulin receptor to the p110alpha subunit of PI3-kinase, which leads to GLUT4 translocation.
Collapse
Affiliation(s)
- T Imamura
- Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California 92093, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Lee ME, Bucur SZ, Gillespie TW, Adams JW, Barker AT, Thomas EK, Roback JD, Hillyer CD. Recombinant human CD40 ligand inhibits simian immunodeficiency virus replication: a role for interleukin- 16. J Med Primatol 1999; 28:190-4. [PMID: 10593485 DOI: 10.1111/j.1600-0684.1999.tb00269.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
CD40 ligand (CD40L), expressed on activated T cells, binds its receptor, CD40, on dendritic cells, B cells, and monocytes/ macrophages. Human immunodeficiency virus (HIV)-infected individuals exhibit normal B-cell CD40 expression but diminished expression of CD40L on CD4 + T cells. Thus, we studied recombinant human CD40L (huCD40L) in an in vitro rhesus macaque model of acquired immunodeficiency syndrome (AIDS). huCD40L induced peripheral blood mononuclear cell (PBMC) proliferation independent of mitogenic cytokines and led to a 70% reduction in p27 production by simian immunodeficiency virus (SIV) mac239 infected PBMCs (P < 0.05). Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis showed reduced expression of SIV gag and increased expression of interleukin (IL)-16 mRNA. Supernatants from huCD40L-stimulated PBMC and control cultures contained similar amounts of IL-16, suggesting an intracellular antiviral effect by IL-16. Phytohemagglutinin (PHA)-stimulated PBMCs similarly cultured with huCD40L showed only slight increases in chemokine production (P > 0.05). These results suggest that huCD40L inhibits replication (antigen and mRNA production) of SIVmac239. This response involves huCD40L induction of IL16 mRNA expression and appears to be independent of beta-chemokines.
Collapse
Affiliation(s)
- M E Lee
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
Three experiments assessed memory skills in good and poor comprehenders, matched for decoding skill. Experiments 1 and 2 investigated phonological and semantic contributions to short-term memory by comparing serial recall for words varying in length, lexicality, and concreteness. Poor comprehenders showed normal sensitivity to phonological manipulations (length and lexicality) but, consistent with their semantic weaknesses, their recall of abstract words was poor. Experiment 3 investigated verbal and spatial working memory. While poor comprehenders achieved normal spatial spans, their verbal spans were impaired. These results are discussed within a theoretical framework in which the memory difficulties associated with poor reading comprehension are specific to the verbal domain and are a concomitant of language impairment, rather than a cause of reading comprehension failure.
Collapse
Affiliation(s)
- K Nation
- Department of Psychology, University of York, Heslington, United Kingdom.
| | | | | | | |
Collapse
|
31
|
Lee ME, Adams JW, Villinger F, Brar SS, Meadows M, Bucur SZ, Lackey DA, Brice GT, Cruikshank WW, Ansari AA, Hillyer CD. Molecular cloning and expression of rhesus macaque and sooty mangabey interleukin 16: biologic activity and effect on simian immunodeficiency virus infection and/or replication. AIDS Res Hum Retroviruses 1998; 14:1323-8. [PMID: 9788673 DOI: 10.1089/aid.1998.14.1323] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Interleukin 16 (IL-16) has been shown to diminish HIV and SIV replication through inhibition of HIV and SIV mRNA transcription. To evaluate its role further, we compared IL-16 cloned from disease-susceptible rhesus macaques and disease-resistant sooty mangabeys. Recombinant rhesus macaque (rr) IL-16 was compared with recombinant sooty mangabey (rm), human, and other nonhuman primate IL-16 sequences and evaluated for its ability to induce chemotaxis and inhibit the mixed lymphocyte response (MLR). Also, rrIL-16 and rmIL-16 were evaluated for suppression of SIVmac251, which replicates efficiently in T cells and monocyte/macrophages (dual tropic), and cloned SIVmac239, which replicates efficiently in T cells (T tropic). Sequence comparison of rrIL-16 and rmIL-16 with human IL-16 showed >97% amino acid identity. Biocharacterization of rrIL-16 revealed potent induction of chemotaxis (p < 0.05) and marked inhibition of MLR (73 +/- 0.6%,p < 0.05) in rhesus and human cell systems. Using rrIL-16 and rmIL-16, p27 antigen production from PBMCs infected with SIVmac251 was decreased up to 70% (p < 0.05 and p < 0.01, respectively). In similar cultures infected with SIVmac239, rrIL-16 and rmIL-16 reduced p27 levels by 96 and 100%, respectively. These data demonstrate the biologic and antiviral functionality of rrIL-16 and rmIL-16.
Collapse
Affiliation(s)
- M E Lee
- Department of Pathology and Laboratory Medicine and the Winship Cancer Center, Emory University School of Medicine, Atlanta, Georgia 30329, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 1998; 95:10140-5. [PMID: 9707614 PMCID: PMC21475 DOI: 10.1073/pnas.95.17.10140] [Citation(s) in RCA: 411] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Receptor-mediated Gq signaling promotes hypertrophic growth of cultured neonatal rat cardiac myocytes and is postulated to transduce in vivo cardiac pressure overload hypertrophy. Although initially compensatory, hypertrophy can proceed by unknown mechanisms to cardiac failure. We used adenoviral infection and transgenic overexpression of the alpha subunit of Gq to autonomously activate Gq signaling in cardiomyocytes. In cultured cardiac myocytes, overexpression of wild-type Galphaq resulted in hypertrophic growth. Strikingly, expression of a constitutively activated mutant of Galphaq, which further increased Gq signaling, produced initial hypertrophy, which rapidly progressed to apoptotic cardiomyocyte death. This paradigm was recapitulated during pregnancy in Galphaq overexpressing mice and in transgenic mice expressing high levels of wild-type Galphaq. The consequence of cardiomyocyte apoptosis was a transition from compensated hypertrophy to a rapidly progressive and lethal cardiomyopathy. Progression from hypertrophy to apoptosis in vitro and in vivo was coincident with activation of p38 and Jun kinases. These data suggest a mechanism in which moderate levels of Gq signaling stimulate cardiac hypertrophy whereas high level Gq activation results in cardiomyocyte apoptosis. The identification of a single biochemical stimulus regulating cardiomyocyte growth and death suggests a plausible mechanism for the progression of compensated hypertrophy to decompensated heart failure.
Collapse
Affiliation(s)
- J W Adams
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Adams JW, Sah VP, Henderson SA, Brown JH. Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes. Circ Res 1998; 83:167-78. [PMID: 9686756 DOI: 10.1161/01.res.83.2.167] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Myocardial infarction results in focal areas of ischemia, hypoxia, necrosis, and decreased contractile function. To compensate for loss of contractile function, remaining viable myocytes undergo hypertrophic growth. Prostaglandin F2alpha (PGF2alpha), which is released from cells of the myocardium during periods of stress such as hypoxia or ischemia/reperfusion, has recently been shown to stimulate hypertrophic growth in neonatal rat ventricular myocytes. In the present study, we determine which growth-related intracellular pathways are required for PGF2alpha to induce morphological and genetic features characteristic of the hypertrophic phenotype. In cardiomyocytes, PGF2alpha increases the hydrolysis of inositol phosphates and induces the translocation of protein kinase C epsilon to the myocyte membrane, consistent with PGF2alpha receptor coupling to Gq. PGF2alpha also activates the extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase pathways. Surprisingly, studies using pharmacological inhibitors and transfection of dominant-interfering proteins demonstrate that PGF2alpha-induced myocyte hypertrophy occurs independent of either PKC, p38, or ERK pathways. Additional studies demonstrate that PGF2alpha stimulates protein tyrosine phosphorylation and activates c-Jun NH2-terminal kinase and suggest that these pathways mediate hypertrophic growth in response to PGF2alpha.
Collapse
Affiliation(s)
- J W Adams
- Department of Pharmacology, University of California, San Diego, La Jolla 92093-0636, USA
| | | | | | | |
Collapse
|
34
|
Bucur SZ, Lackey DA, Adams JW, Lee ME, Villinger F, Mayne A, Bray RA, Winton EF, Novembre F, Strobert EA, De Rosayro J, Dailey PJ, Ansari AA, Hillyer CD. Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques. AIDS Res Hum Retroviruses 1998; 14:651-60. [PMID: 9618076 DOI: 10.1089/aid.1998.14.651] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The hematologic abnormalities of SIV and HIV are well described, although the mechanisms that lead to hematopoietic dysfunction are yet to be fully defined. A number of growth factors and cytokines have been used to induce the differentiation, maturation, and proliferation of appropriate lineages, with the aim that such therapy will lead to functional hematopoietic reconstitution. Within this context, some cytokines have been shown to influence HIV and SIV replication in vitro and, in selected cases, in vivo. However, few studies detail the effects of hematopoietic cytokines such as IL-3, Flt-3 ligand, G-CSF, Tpo, and Epo or correlate the effects on virus replication. In an effort to address this issue, we infected 12 rhesus macaques with 500 TCID50 of SIVmac239 and intensively evaluated hematologic, virologic, and immunologic parameters during administration of cytokines. When all animals had lymphadenopathy, hepatosplenomegaly, and CD4+ cell counts > or =1000/microl, subgroups of three rhesus macaques were administered either rhFlt-3; rrIL-3a; combination of rhG-CSF, rhTpo, and rhEpo (rhGET); or rrIL-12. Fourteen days of rhFlt-3 administration induced expansion of the bone marrow CD34+ cells and granulocyte-macrophage colony-forming units (GM-CFUs) and increased absolute peripheral blood CD34+ cells and total CFUs. Following rrIL-3 and rhGET administration absolute peripheral blood CD34+ cells and total CFUs increased. rhGET also increased granulocyte, platelet, and reticulocyte counts by day 14 of administration. Branched DNA and coculture assays did not demonstrate any significant change in viral load with any of the cytokines administered. These data suggest that SIV-infected rhesus macaques have the hematopoietic capability to expand and mobilize CD34+ and GM-CFU progenitors and formed elements at 6-8 months postinfection in response to various cytokines, without increasing viral load.
Collapse
Affiliation(s)
- S Z Bucur
- Department of Pathology, Emory University, Atlanta, Georgia 30322, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Bostik P, Villinger F, Brice GT, Chikkala NF, Brar SS, Cruikshank WW, Adams JW, Hillyer CD, Ansari AA. Expression and in vitro evaluation of rhesus macaque wild type (wt) and modified CC chemokines. J Med Primatol 1998; 27:113-20. [PMID: 9747952 DOI: 10.1111/j.1600-0684.1998.tb00235.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Several human CC chemokines have been shown to inhibit HIV/ SIV infection in vitro, providing the rationale for their potential use in vivo. However, because of their inherent physiological effect, such chemokines are reasoned to be of limited therapeutic value due to potential side effects. The knowledge that amino terminus modified or deleted human RANTES retains its receptor binding properties but loses its signaling properties has provided a means to use such modified chemokines in vivo for possible therapeutic benefits. In efforts to test the efficacy of such modified chemokines, our laboratory has cloned, sequenced, and prepared recombinant forms of wild-type (wt) and amino-terminus modified rhesus macaque chemokines MIP-1alpha, MIP-1beta, and RANTES. These sets of chemokines were tested for their potential to inhibit SIV infection and induce signaling. The data showed that whereas wt chemokines retained both virus inhibitory and signaling functions, corresponding amino-terminus modified chemokines only showed virus inhibitory effects without detectable signaling effects. Such reagents will be valuable for evaluation of their therapeutic potential in vivo, either alone or as adjuncts to other chemotherapeutic drugs.
Collapse
Affiliation(s)
- P Bostik
- Department of Pathology and Laboratory Medicine and the Winship Cancer Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Abstract
Two experiments investigated the extent to which children's mental arithmetic is constrained by working memory rather than their arithmetical competence. A span procedure was used to measure the limit on English- and German-speaking children's ability to add together pairs of multidigit numbers. The children's ages ranged from 7 years 7 months to 11 years 5 months. Spans for mental addition were higher when the numbers to be added were visible throughout calculation than when they were not, consistent with a working memory constraint. Variation in addition span with children's age and with difficulty of the arithmetical operations approximated to a linear function of the speed of adding integers. A similar speed/span relationship has previously been observed for counting span, an artificial task designed to load working memory by combining separate processing and storage subtasks. We conclude that the natural task of mental addition, which combines processing and storage as intrinsic components, reflects working memory in a similar way. Results were remarkably similar both between cultures and across age groups, consistent with the notion of working memory as a general-purpose resource with dynamics that are indifferent to the detailed nature of operations.
Collapse
Affiliation(s)
- J W Adams
- Department of Psychology, University of York, York, Heslington, YO1 5DD, United Kingdom.
| | | |
Collapse
|
37
|
Adams JW. Event medicine and attendance medicine. Pharos Alpha Omega Alpha Honor Med Soc 1997; 60:47. [PMID: 9270280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
38
|
Abstract
Adherent cultures of neonatal rat cardiomyocytes were subjected to progressive, unidirectional lengthening for 2-4 days in serum-containing medium. This mechanical stretch (25% increase in initial length each day) simulates the eccentric mechanical load placed on in vivo heart cells by increases in postnatal blood pressure and volume. The in vitro mechanical stimuli initiated a number of morphological alterations in the confluent cardiomyocyte population which were similar to those occurring during in vivo heart growth. These include cardiomyocyte organization into parallel arrays of rod-shaped cells, increased cardiomyocyte binucleation, and cardiomyocyte hypertrophy by longitudinal cell growth. Stretch stimulated DNA synthesis in the noncardiomyocyte population but not in the cardiomyocytes. Myosin heavy chain (MHC) content increased 62% over 4 days of stretch and included increased accumulation of both fetal beta-MHC and adult alpha-MHC isoforms. This new model of stretch-induced cardiomyocyte hypertrophy may assist in examining some of the complex mechanogenic growth processes that occur in the rapidly enlarging neonatal heart.
Collapse
Affiliation(s)
- H H Vandenburgh
- Department of Pathology and Laboratory Medicine, Brown University School of Medicine, Providence, Rhode Island, USA
| | | | | | | | | |
Collapse
|
39
|
Adams JW, Migita DS, Yu MK, Young R, Hellickson MS, Castro-Vargas FE, Domingo JD, Lee PH, Bui JS, Henderson SA. Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem 1996; 271:1179-86. [PMID: 8557648 DOI: 10.1074/jbc.271.2.1179] [Citation(s) in RCA: 77] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Prostaglandin F2 alpha (PGF2 alpha) stimulates protein synthesis of skeletal and smooth muscle cells in culture and is elevated in the heart during compensatory growth. We hypothesized that PGF2 alpha stimulates hypertrophic growth of neonatal rat cardiac myocytes. Prostaglandin F2 alpha increased [3H]phenylalanine incorporation by cultured ventricular myocytes in a dose-dependent manner (EC50 = 11 nM), suggesting action through a PGF-specific receptor. Semiquantitative reverse transcriptase polymerase chain reaction revealed that PGF receptor mRNA is expressed in ventricular myocytes > A7R5 vascular smooth muscle cells >> cardiac fibroblast-like cells. The protein content of cardiomyocyte cultures was increased by 10 nM PGF2 alpha and 11 beta-PGF2 alpha but was unchanged by 10 nM PGD2, PGE2, PGF1 alpha, carbaprostacyclin, U-46619, or 12- or 15-hydroxyeicosatrienoic acid. Stimulation of myofibrillar gene expression by PGF2 alpha was demonstrated by Northern and Western blot analysis for myosin light chain-2 (MLC-2) and by transient transfection experiments with MLC-2 luciferase expression plasmids. In addition, myofibrillogenesis was increased by PGF2 alpha as assessed by immunocytochemical staining with MLC-2 antisera. Prostaglandin F2 alpha did not affect myocyte proliferation or [3H]thymidine incorporation, thus myocyte growth occurred by hypertrophy. Proliferative and hypertrophic growth of cardiac fibroblast-like cells were unaffected by PGF2 alpha. We conclude that PFG2 alpha stimulates hypertrophic growth of neonatal rat ventricular myocytes in culture and speculate that PGF2 alpha plays a role in myocardial adaptation to chronic hypertrophic stimuli, recovery from injury, and cardiac ontogeny.
Collapse
Affiliation(s)
- J W Adams
- Department of Physiological Science, UCLA 90095, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Kasakoff AB, Adams JW. The effect of migration on ages at vital events: a critique of family reconstitution in historical demography. Eur J Popul 1995; 11:199-242. [PMID: 12158998 DOI: 10.1007/bf01264948] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
Vandenburgh HH, Solerssi R, Shansky J, Adams JW, Henderson SA, Lemaire J. Response of neonatal rat cardiomyocytes to repetitive mechanical stimulation in vitro. Ann N Y Acad Sci 1995; 752:19-29. [PMID: 7755258 DOI: 10.1111/j.1749-6632.1995.tb17403.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- H H Vandenburgh
- Department of Pathology, Brown University School of Medicine, Providence, Rhode Island, USA
| | | | | | | | | | | |
Collapse
|
42
|
Henderson SA, Lee PH, Aeberhard EE, Adams JW, Ignarro LJ, Murphy WJ, Sherman MP. Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J Biol Chem 1994; 269:25239-42. [PMID: 7523382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Since early growth response-1 (Egr-1) is required for macrophage differentiation and nitric oxide (NO) is immunosuppressive, we hypothesized that NO would reduce Egr-1 expression in rat lung macrophages. The inflammatory stimuli interferon-gamma and lipopolysaccharide induced an early, transient increase in Egr-1 mRNA (> 5-fold at 2 h) and a sustained, high level of inducible NO synthase mRNA (> 100-fold from 4 to 24 h). The NO metabolites nitrite and nitrate rose > 10-fold in medium from stimulated versus unstimulated cells over 24 h. Concomitant with elevated nitrogen oxides, Egr-1 mRNA levels declined to 80% below unstimulated cells at 24 h. This decline was blocked by an inhibitor of NO production, NG-monomethyl-L-arginine. Further, the NO donor S-nitroso-N-acetylpenicillamine inhibited Egr-1 expression in a dose-dependent manner, producing complete inhibition at 0.5 mM. The effect of S-nitroso-N-acetylpenicillamine was not due to reduced macrophage viability. We conclude that Egr-1 induction precedes inducible NO synthase induction in stimulated rat macrophages and that subsequent NO production reduces macrophage expression of Egr-1. We propose that this mechanism is used to regulate macrophage differentiation in human immunodeficiency virus infection and other inflammatory states.
Collapse
|
43
|
Henderson SA, Lee PH, Aeberhard EE, Adams JW, Ignarro LJ, Murphy WJ, Sherman MP. Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J Biol Chem 1994. [DOI: 10.1016/s0021-9258(18)47236-5] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
44
|
Adams JW. Development of sports medicine. N C Med J 1994; 55:488-92. [PMID: 7800063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- J W Adams
- Bowman Gray School of Medicine, Winston-Salem 27157
| |
Collapse
|
45
|
Abstract
The hypoplastic finger with metacarpal base defect is a rare anomaly. Metacarpal lengthening is not a reasonable treatment option because of severe hypoplasia of the metacarpal. Complete amputation with closure of the interdigital space is effective but most parents want to save any digit of their child. We prefer to release the syndactyly and save the finger, with its shortened three phalanges, during childhood. Our parents and patients have been satisfied with the short digit. At a later age the metacarpal of the hypoplastic finger can be fused to one or the other adjacent metacarpals. Alternative methods to increase function and improve appearance are presented.
Collapse
Affiliation(s)
- V E Wood
- Department of Orthopaedic Surgery, Loma Linda University Medical Center, CA 92350
| | | |
Collapse
|
46
|
|
47
|
Abstract
As practicing intensivists, we frequently diagnose pleural effusions in mechanically ventilated patients and routinely perform thoracentesis even when the patient is on positive end-expiratory pressure (PEEP). In light of a recent report, we have reviewed our experience. It is of interest that all thoracenteses were performed with patients in the lateral decubitus position.
Collapse
Affiliation(s)
- J P McCartney
- Baptist Memorial Hospital-Medical Center, Memphis, Tenn
| | | | | |
Collapse
|
48
|
Ma MT, Adams JW. Characteristics of Unknown Linear Systems Deduced from Measured CW Magnitude. J Res Natl Inst Stand Technol 1993; 98:297-319. [PMID: 28053476 PMCID: PMC4914238 DOI: 10.6028/jres.098.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Accepted: 12/17/1992] [Indexed: 06/06/2023]
Abstract
A method is presented for predicting the total response, in both frequency and time, of an unknown linear system when only the measured continuous wave (cw) magnitude is available. The approach is based on approximating the square of the measured magnitude by a rational function, from which various system transfer functions in terms of complex frequency are deduced. These transfer functions may or may not be at minimum phase. The corresponding impulse response is then obtained by taking the inverse Laplace transform of the transfer function. The impulse response of the minimum-phase case rises faster initially to its first maximum than the nonminimum-phase counterparts. This result confirms that, for the same cw magnitude response, the accumulative energy contained in the impulse response is the greatest when the transfer function is at minimum phase. Physical meaning of the energy content is also discussed.
Collapse
Affiliation(s)
- M T Ma
- National Institute of Standards and Technology, Boulder, CO 80303-3328
| | - J W Adams
- National Institute of Standards and Technology, Boulder, CO 80303-3328
| |
Collapse
|
49
|
|
50
|
Richards B, Adams JW. Shortcomings of acute physiology and chronic health evaluation II. Crit Care Med 1992; 20:309. [PMID: 1737465 DOI: 10.1097/00003246-199202000-00023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|